This site is intended for US residents only.

• HTML Foundation Styles

 

HTML tags Font Name Font Size Line Height
<h1></h1>

Montserrat

 61px 73px
<h2></h2>

Montserrat

 49px 59px
<h3></h3>

Montserrat

 39px 47px
<h4></h4>

Montserrat

 31px 37px
<h5></h5>
Montserrat
 25px 30px
<h6></h6>
Montserrat
 20px 24px
<p></p>

IBM Plex Sans

 16px 26px
<b></b>

Montserrat

 16px 19px

 

 

• Strong Font Styles

ℹ️ It was tested in headings and paragraphs.

 

HTML tags Strong Font Styles Font Name Font Size Line Height
<h1-h6> Step 5 Montserrat 61px 73px
<p> Step 5 IBM Plex Sans 61px 98px
<p><b> Step 5 Montserrat 61px 73px
<h1-h6> Step 4 Montserrat 49px 59px
<p> Step 4 IBM Plex Sans 49px 78px
<p><b> Step 4 Montserrat 49px 59px
<h1-h6> Step 3 Montserrat 39px 47px
<p> Step 3 IBM Plex Sans 39px 62px
<p><b> Step 3 Montserrat 39px 47px
<h1-h6> Step 2 Montserrat 31px 37px
<p> Step 2 IBM Plex Sans 31px 50px
<p><b> Step 2 Montserrat 31px 47px
<h1-h6> Step 1 Montserrat 25px 30px
<p> Step 1 IBM Plex Sans 25px 40px
<p><b> Step 1 Montserrat 25px 30px
<h1-h6> Step 0 Montserrat 20px 24px
<p> Step 0 IBM Plex Sans 20px 32px
<p><b> Step 0 Montserrat 20px 24px
<h1-h6> Step -1 Montserrat 16px 19px
<p> Step -1 IBM Plex Sans 16px 26px
<p><b> Step -1 Montserrat 16px 19px
<h1-h6> Step -2 Montserrat 13px 15px
<p> Step -2 IBM Plex Sans 13px 20px
<p><b> Step -2 Montserrat 13px 15px
<h1-h6> Step -3 Montserrat 10px 12px
<p> Step -3 IBM Plex Sans 10px 16px
<p><b> Step -3 Montserrat 10px 12px

💡 Examples:

 

h1-h6: Step 5

p: Step 5

p + b : Step 5

h1-h6: Step 4

p: Step 4
p + b : Step 4

h1-h6: Step 3

p: Step 3

p + b : Step 3

h1-h6: Step 2

p: Step 2

p + b : Step 2

h1-h6: Step 1

p: Step 1

p + b : Step 1

h1-h6: Step 0

p: Step 0

p + b : Step 0

h1-h6: Step -1

p: Step -1

p + b : Step -1

h1-h6: Step -2

p: Step -2

p + b : Step -2

h1-h6: Step -3

p: Step -3

p + b : Step -3

• Text Font Styles

⚠️ It only applies to paragraphs; it doesn’t work in headings.

 

HTML tags Text Font Styles Font Name Font Size Line Height
<p> Step 2 IBM Plex Sans 31px 50px
<p> Step 1 IBM Plex Sans 25px 40px
<p> Step 0 IBM Plex Sans 20px 32px
<p> Step -1 IBM Plex Sans 16px 26px
<p> Step -2 IBM Plex Sans 13px 20px
<p> Step -3 IBM Plex Sans 10px 16px
- - - - - - - - - - - -
HTML tags Text Font Styles Font Name Font Size Line Height
<p><b> Step 2 IBM Plex Sans 31px 50px
<p><b> Step 1 IBM Plex Sans 25px 40px
<p><b> Step 0 IBM Plex Sans 20px 32px
<p><b> Step -1 IBM Plex Sans 16px 26px
<p><b> Step -2 IBM Plex Sans 13px 20px
<p><b> Step -3 IBM Plex Sans 10px 16px

💡 Examples:

 

p: Step 2

p: Step 2

p: Step 0

p: Step -1

p: Step -2

p: Step -3

 

 

 

 

 

 

💡 Examples b:

 

p: Step 2

p: Step 2

p: Step 0

p: Step -1

p: Step -2

p: Step -3

• Bold Pattern

ℹ️ It was tested in headings and paragraphs.

 

HTML tags Bold Pattern Font Name Font Size Line Height
h1 Light Montserrat 61px 73px
h2 Light Montserrat 49px 59px
h3 Light Montserrat 39px 47px
h4 Light Montserrat 31px 37px
h5 Light Montserrat 25px 30px
h6 Light Montserrat 20px 24px
p Light IBM Plex Sans 16px 26px
 
h1 Light Italic Montserrat 61px 73px
h2 Light Italic Montserrat 49px 59px
h3 Light Italic Montserrat 31px 37px
h4 Light Italic Montserrat 25px 30px
h5 Light Italic Montserrat 20px 24px
h6 Light Italic Montserrat 16px 26px
p Light Italic IBM Plex Sans 16px 26px
 
h1 Regular Montserrat 61px 73px
h2 Regular Montserrat 49px 59px
h3 Regular Montserrat 31px 37px
h4 Regular Montserrat 25px 30px
h5 Regular Montserrat 20px 24px
h6 Regular Montserrat 16px 26px
p Regular IBM Plex Sans 16px 26px
 
h1 Italic Montserrat 61px 73px
h2 Italic Montserrat 49px 59px
h3 Italic Montserrat 31px 37px
h4 Italic Montserrat 25px 30px
h5 Italic Montserrat 20px 24px
h6 Italic Montserrat 16px 26px
p Italic IBM Plex Sans 16px 26px
 
h1 Semi Bold Montserrat 61px 73px
h2 Semi Bold Montserrat 49px 59px
h3 Semi Bold Montserrat 39px 47px
h4 Semi Bold Montserrat 31px 37px
h5 Semi Bold Montserrat 25px 30px
h6 Semi Bold Montserrat 20px 24px
p Semi Bold IBM Plex Sans 16px 26px
 
h1 Semi Bold Italic Montserrat 61px 73px
h2 Semi Bold Italic Montserrat 49px 59px
h3 Semi Bold Italic Montserrat 39px 47px
h4 Semi Bold Italic Montserrat 31px 37px
h5 Semi Bold Italic Montserrat 25px 30px
h6 Semi Bold Italic Montserrat 20px 24px
p Semi Bold Italic IBM Plex Sans 16px 26px
 
h1 Bold Montserrat 61px 73px
h2 Bold Montserrat 49px 59px
h3 Bold Montserrat 39px 47px
h4 Bold Montserrat 31px 37px
h5 Bold Montserrat 25px 30px
h6 Bold Montserrat 20px 24px
p Bold IBM Plex Sans 16px 26px
Bold Italic
h1 Bold Italic Montserrat 61px 73px
h2 Bold Italic Montserrat 49px 59px
h3 Bold Italic Montserrat 39px 47px
h4 Bold Italic Montserrat 31px 37px
h5 Bold Italic Montserrat 25px 30px
h6 Bold Italic Montserrat 20px 24px
p Bold Italic IBM Plex Sans 16px 26px

💡 Examples:

 

h1: Light

h2: Light

h3: Light

h4: Light

h5: Light
h6: Light

p: Light

h1: Light Italic

h2: Light Italic

h3: Light Italic

h4: Light Italic

h5: Light Italic
h6: Light Italic

p: Light Italic

h1: Regular

h2: Regular

h3: Regular

h4: Regular

h5: Regular
h6: Regular

p: Regular

h1: Italic

h2: Italic

h3: Italic

h4: Italic

h5: Italic
h6: Italic

p: Italic

h1: Semi Bold

h2: Semi Bold

h3: Semi Bold

h4: Semi Bold

h5: Semi Bold
h6: Semi Bold

p: Semi Bold

h1: Semi Bold Italic

h2: Semi Bold Italic

h3: Semi Bold Italic

h4: Semi Bold Italic

h5: Semi Bold Italic
h6: Semi Bold Italic

p: Semi Bold Italic

h1: Bold 

h2: Bold 

h3: Bold 

h4: Bold 

h5: Bold 
h6: Bold 

p: Bold 

h1: Bold Italic

h2: Bold Italic

h3: Bold Italic

h4: Bold Italic

h5: Bold Italic
h6: Bold Italic

p: Bold Italic

What is VYLOY?

IMPORTANT SAFETY INFORMATION

What is VYLOY?

VYLOY is a prescription medicine used to treat adults with cancer of the stomach (gastric cancer) or cancer located where the esophagus joins the stomach (gastroesophageal junction cancer). VYLOY is used in combination with chemotherapy that contains fluoropyrimidine and platinum as the first treatment when your gastric or gastroesophageal junction cancer:

  • cannot be removed with surgery or has spread to other parts of the body,
  • is HER2-negative, and
  • your tumor tests positive for “claudin (CLDN)18.2.”

It is not known if VYLOY is safe and effective in children.

Before receiving VYLOY, tell your healthcare provider about all of your medical conditions, including if you:

  • have nausea or vomiting.
  • are pregnant or plan to become pregnant. It is not known if VYLOY will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if VYLOY passes into your breast milk. Do not breastfeed during treatment with VYLOY and for 8 months after the last dose.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of VYLOY?

VYLOY may cause serious side effects, including:

  • Allergic reactions, including anaphylaxis and infusion-related reactions. Allergic reactions are common during treatment with VYLOY and can sometimes be serious. Serious allergic reactions can happen during or after your VYLOY infusion, including life-threatening allergic reactions and serious infusion-related reactions that may lead to death. Your healthcare provider will monitor you during your infusion and for 2 hours after or longer if needed. Tell your healthcare provider or get emergency medical help right away if you get any of the following symptoms of a serious allergic reaction during or after your infusion of VYLOY:
  • itchy, raised bumps on the skin (hives)
  • coughing that does not go away
  • nausea or vomiting
  • stomach (abdominal) pain
  • increased saliva
  • breathing problems such as wheezing
  • throat tightness or change in voice
  • fever
  • chest discomfort
  • chills or shaking
  • back pain
  • Severe nausea and vomiting. Nausea and vomiting are common during treatment with VYLOY and can sometimes be severe. Nausea and vomiting happened more often during the first treatment cycle. Before you receive each VYLOY infusion, your healthcare provider will give you medicines to help prevent nausea and vomiting. Tell your healthcare provider right away if nausea or vomiting does not go away or gets worse.

The most common side effects of VYLOY include:

  • tiredness
  • decreased appetite
  • diarrhea
  • tingling or numbness of the arms or legs
  • stomach (abdominal) pain
  • constipation
  • decreased weight
  • fever
  • decreased white blood cells, red blood cells and platelets
  • decreased protein (albumin) in the blood
  • changes in kidney function tests
  • changes in blood sugar (glucose)
  • changes in liver function tests
  • changes in body salts (electrolytes) in your blood

Your healthcare provider may slow the rate of your infusion, temporarily stop, or completely stop treatment with VYLOY if you have certain side effects. These are not all of the possible side effects of VYLOY. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-10881-800-FDA-1088 or www.fda.gov/medwatch.

Please see full Prescribing Information, including Patient Information.

What is VYLOY?

IMPORTANT SAFETY INFORMATION

What is VYLOY?

VYLOY is a prescription medicine used to treat adults with cancer of the stomach (gastric cancer) or cancer located where the esophagus joins the stomach (gastroesophageal junction cancer). VYLOY is used in combination with chemotherapy that contains fluoropyrimidine and platinum as the first treatment when your gastric or gastroesophageal junction cancer:

  • cannot be removed with surgery or has spread to other parts of the body,
  • is HER2-negative, and
  • your tumor tests positive for “claudin (CLDN)18.2.”

It is not known if VYLOY is safe and effective in children.

Before receiving VYLOY, tell your healthcare provider about all of your medical conditions, including if you:

  • have nausea or vomiting.
  • are pregnant or plan to become pregnant. It is not known if VYLOY will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if VYLOY passes into your breast milk. Do not breastfeed during treatment with VYLOY and for 8 months after the last dose.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of VYLOY?

VYLOY may cause serious side effects, including:

  • Allergic reactions, including anaphylaxis and infusion-related reactions. Allergic reactions are common during treatment with VYLOY and can sometimes be serious. Serious allergic reactions can happen during or after your VYLOY infusion, including life-threatening allergic reactions and serious infusion-related reactions that may lead to death. Your healthcare provider will monitor you during your infusion and for 2 hours after or longer if needed. Tell your healthcare provider or get emergency medical help right away if you get any of the following symptoms of a serious allergic reaction during or after your infusion of VYLOY:
  • itchy, raised bumps on the skin (hives)
  • coughing that does not go away
  • nausea or vomiting
  • stomach (abdominal) pain
  • increased saliva
  • breathing problems such as wheezing
  • throat tightness or change in voice
  • fever
  • chest discomfort
  • chills or shaking
  • back pain
  • Severe nausea and vomiting. Nausea and vomiting are common during treatment with VYLOY and can sometimes be severe. Nausea and vomiting happened more often during the first treatment cycle. Before you receive each VYLOY infusion, your healthcare provider will give you medicines to help prevent nausea and vomiting. Tell your healthcare provider right away if nausea or vomiting does not go away or gets worse.

The most common side effects of VYLOY include:

  • tiredness
  • decreased appetite
  • diarrhea
  • tingling or numbness of the arms or legs
  • stomach (abdominal) pain
  • constipation
  • decreased weight
  • fever
  • decreased white blood cells, red blood cells and platelets
  • decreased protein (albumin) in the blood
  • changes in kidney function tests
  • changes in blood sugar (glucose)
  • changes in liver function tests
  • changes in body salts (electrolytes) in your blood

Your healthcare provider may slow the rate of your infusion, temporarily stop, or completely stop treatment with VYLOY if you have certain side effects. These are not all of the possible side effects of VYLOY. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-10881-800-FDA-1088 or www.fda.gov/medwatch.

Please see full Prescribing Information, including Patient Information.